美国Diatherix 
该公司提供一系列有关院内感染快速检测的服务
成立于2008年的Diatherix公司是全球首家在“分子鉴别诊断”领域持有CLIA执照的参比实验室.2006年秋，韩健在美国集资创办的公司Genaco被世界上最大的分子诊断公司QIAGEN以4000万美金收购后，即加入哈森成为研究员。Diatherix公司的实验室主任。

DIATHERIX Laboratories is an emerging leader in infectious disease diagnostics and drug resistance detection services. Using a multiplexing platform, DIATHERIX Laboratories has developed a series of molecular differential diagnostic services that enable unprecedented speed and accuracy for health care providers in the identification of disease-producing pathogens, leading to appropriate treatment for patients. DIATHERIX Laboratories is a CLIA certified laboratory that is also involved with clinical trials for future products and pharmaceutical development.